Our very own Dr. Louise Oni will be leading the LifeArc-Kidney Research UK Centre for Rare Kidney Diseases thanks to a £9.4m funding award. 🔬🏥

The new centre will develop new and improved methods for treating kidney disease in children.

Read more ➡️➡️news.liverpool.ac.uk/2024/04/23/9-4…

IgG subclass guide in membranous nephropathy (from Renal Pathology Society meeting):

The second Austrian Mayo Clinic meeting is happening in 18 days in the 'Mozart' city Salzburg. It is not too late to register for this event: mayoclinic.congressinfo.eu
We are looking forward to two days of networking and discussions.

Vacation makes me tired.

Storm coming; Rovinj.

✅ It is my IMMENSE PLEASURE to share with you our SEMINAR on systemic #Lupus just published in... The LANCET!!!!! Amazing work driven by Alberta Hoi 👍
LINK: authors.elsevier.com/a/1ixq7V-4XOrME

A great topic! 🚀

Also, check our initiative if you want to review papers for NDT and CKJ.

ERA - European Renal Association

forms.office.com/pages/response…

A pre-specified interim analysis of APPLAUSE-IgAN P3 RCT demonstrates 38% UPCR reduction vs. placebo at 9 months; first such results showcasing the power of complement targeting in IgAN.

novartis.com/news/media-rel…

Feel free to drop your foggy photos in the comments!

Our ‘Meet and Greet’ will be on Friday, May 24, 2024, in Stockholm, Sweden during the 61st ERA - European Renal Association Congress from 19:30 to 22:00 (CEST).

Do not forget to sign up! Spots are limited!

forms.office.com/pages/response…

MPGN simplified.

CJASN Thanks, but how about those pts treated with SGLT2i that do not have anaemia upfront???

🧐Beware of SGLT2i-induced erythrocytosis, which was never reported in any of the RCTs but occurs in clinical practice

⏩ajkd.org/article/S0272-…

Every single flare of LN increases the risk of non-response to treatment, development of CKD and KF! A piece led by Eleni Frangou and published in JASN_News! A pleasure to work with these amazing co-authors as tagged by Hans-Joachim Anders

Ready to apply to our Postdoctoral Fellowships 2024 call? Get all the steps right!

1️⃣Learn about funding basics
2️⃣Check your eligibility
3️⃣Hunt host organisations
4️⃣Draft your application
5️⃣Get feedback from experts
6️⃣Submit your application!

More info: europa.eu/!dB783t

Shout out to a very good 2022 KI Rep overview on this by Tiffany Caza:
kireports.org/article/S2468-…

To diagnose anti-GBM disease in the absence of circulating antibodies remains a big challenge. Our response to this recent paper in AJKD (sciencedirect.com/science/articl…) can be found here (sciencedirect.com/science/articl…). It needs more stringent criteria to make such a diagnosis

A good read elucidating a very interesting and difficult part of glomerular diseases!

Great pleasure to discuss Renal Relapse in #ANCA with Andreas Kronbichler, Mark Little of Trinity Kidneys and Irmi Neumann in a workshop at #VasculitisBCN2024 - challenging but there is exciting progress with novel biomarkers such as proposed in JASN_News
journals.lww.com/jasn/citation/…

Our comment includes a wonderful pic by Tiffany Caza from Arkana Laboratories showing morphologic mimics of 'atypical' anti-GBM! Andreas Kronbichler AJKD

ajkd.org/article/S0272-…

Is every linear staining anti-GBM disease? What is 'atypical' anti-GBM disease & when is it something completely different? Read the study by Chauveau et al., editorial by Lynn D. Cornell, M.D. & our comment by Tiffany Caza & Andreas Kronbichler published in AJKD

ajkd.org/article/S0272-…